67 completed, 31 recruiting, 15 unknown, 14 terminated. 148 Phase 2, 26 Phase 1, 15 Phase 3.
Follow Cannabidiol: new trials by email Literature Review of Cannabidiol trials Research Report on Cannabidiol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis Cannabidiol (CBD), Placebo - Schizophrenia Spectrum Disorders, Cannabis Use | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2050-01-01 | 2021-04-19 | |
| Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving Cannabidiol (CBD), Placebo - Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification | Phase 2 / Phase 3 | Recruiting | Johns Hopkins University | 105 | 2026-10-21 | 2026-11-03 |
| Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome Epidiolex 100 mg/mL Oral Solution - Sturge - Weber Syndrome (SWS) | Phase 2 | Recruiting | Johns Hopkins University | 10 | 2026-09-17 | 2026-10-02 |
| Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery Cannabidiol (CBD) only, Placebo only, Delta-9-tetrahydrocannabinol (THC) only - PTSD, Post Traumatic Stress Disorder | Phase 1 / Phase 2 | Not yet recruiting | Leslie Lundahl | 280 | 2026-09-01 | 2026-08-26 |
| Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use Cannabidiol, Placebo - Sleep, Alcohol Misuse | Phase 2 | Not yet recruiting | University of Colorado, Boulder | 58 | 2026-07-01 | 2026-06-11 |
| CBD Knee Osteoarthritis Study Cannabidiol (CBD), Castor Oil (Placebo) - Osteoarthitis | Phase 2 | Not yet recruiting | University of Tennessee | 30 | 2026-07-01 | 2026-06-10 |
| Cannabidiol for Pain Relief of Patients With End-stage mCRPC Cannabidiol, Placebo - Metastatic Castration Resistant Prostate Cancer (mCRPC) | Phase 2 | Recruiting | Regionshospital Nordjylland | 58 | 2026-06-12 | 2026-09-16 |
| nVNS, CBD, and SoC for Persistent Post-Traumatic Headache Non-Invasive Vagus Nerve Stimulation, Cannabidiol, Standard of Care - Persistent Post Traumatic Headache | Phase 2 | Not yet recruiting | American Society of Pain and Neuroscience, Inc. | 80 | 2026-06-01 | 2026-06-03 |
| Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders. Cannabidiol - Neurodevelopmental Disorders With Severe Self-injuries | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 21 | 2026-05-01 | 2026-05-04 |
| Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study Cannabidiol (CBD) oral solution, Full-Spectrum CBD hemp extract oral solution, Placebo in MCT oil oral solution - Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies | Phase 1 / Phase 2 | Recruiting | Florida A&M University | 20 | 2026-04-02 | 2026-04-29 |
| Study of Cannabidiol in Sanfilippo Syndrome Epidiolex, Placebo - Sanfilippo Syndrome, Mucopolysaccharidosis III | Phase 2 / Phase 3 | Recruiting | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 35 | 2026-04-01 | 2026-09-15 |
| The Effect of CBD on Sleep Quality Following Late Evening Exercise Cannabidiol or placebo, late evening exercise - Sleep Quality | Phase 2 | Recruiting | KU Leuven | 20 | 2026-03-19 | 2026-05-06 |
| CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury CBD - Supra-sacral Spinal Cord Injury, Spinal Cord Injury | Phase 2 | Recruiting | University of Wisconsin, Madison | 20 | 2026-02-13 | 2026-09-16 |
| Cannabis (THC vs. CBD) in Multiple Sclerosis THC, CBD - Multiple Sclerosis | Phase 2 | Recruiting | University of Calgary | 30 | 2025-12-05 | 2026-09-15 |
| Study of Cannabidiol and Neuroimaging on Stress Cannabidiol, Placebo - Early Life Adversity, Trauma | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 160 | 2025-10-29 | 2026-09-10 |
| Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors Biospecimen Collection, Cannabidiol, Dronabinol - Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Recruiting | City of Hope Medical Center | 120 | 2025-10-03 | 2025-12-05 |
| Warrior CARE: Cannabis Behavioral Health Tetrahydrocannabinol, Cannabidiol, Placebo - Post Traumatic Stress Disorder, Cannabis Use | Phase 1 / Phase 2 | Recruiting | Wayne State University | 500 | 2025-09-22 | 2026-08-07 |
| A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence Cannabidiol capsules, Naltrexone (drug), Placebo - Alcohol Addiction, Alcoholism | Phase 2 | Recruiting | Central Institute of Mental Health, Mannheim | 150 | 2025-07-22 | 2026-02-03 |
| Topical Cannabidiol for Treating Carpal Tunnel Syndrome Cannabidiol - Carpal Tunnel Syndrome | Phase 2 | Not yet recruiting | University of Virginia | 20 | 2025-07-01 | 2025-04-11 |
| Unique Treatment of Oncology Pain in Advanced Cancer Trichomylin® capsule (5 mg delta-9-tetrahydrocannabinol: 5 mg cannabidiol: 5 mg cannabichromene) - Cancer Pain | Phase 2 | Completed | ZYUS Life Sciences Inc. | 11 | 2025-06-12 | 2026-09-01 |
Showing 20 of 148. Sign in to see all of them.
Marijuana Abuse (24) · Alcoholism (9) · Anxiety Disorders (9) · Pain (8) · Schizophrenia (8) · Stress Disorders, Post-Traumatic (8) · Opioid-Related Disorders (7) · Psychotic Disorders (7) · Epilepsy (6) · Multiple Sclerosis (4) · Autism Spectrum Disorder (3) · COVID-19 (3) · Chronic Pain (3) · Cognitive Dysfunction (3) · Graft vs Host Disease (3)
Jazz Pharmaceuticals (8) · University of Colorado, Denver (8) · NYU Langone Health (5) · University of California, San Diego (5) · Rabin Medical Center (4) · Radius Pharmaceuticals, Inc. (4) · Central Institute of Mental Health, Mannheim (3) · Johns Hopkins University (3) · Mayo Clinic (3) · Mclean Hospital (3) · Medical University of South Carolina (3) · University of California, Los Angeles (3) · Anne Comi, MD (2) · Assistance Publique - Hôpitaux de Paris (2) · Brigham and Women's Hospital (2)
United States (87) · Canada (9) · United Kingdom (9) · Israel (8) · Brazil (6) · Germany (6) · Spain (6) · Australia (5) · Denmark (5) · France (4) · Netherlands (4) · Poland (3) · Sweden (2) · Argentina (1) · Belgium (1)
Ahmed Elkashef, MD (4) · F. Markus Leweke, MD (3) · Anne M Comi, MD (2) · Dennis McNamara, MD (2) · Kent Hutchison, PhD (2) · Moshe Yeshurun, MD (2) · Nathaniel M Schuster, MD (2) · Neha Parikh (2) · Yasmin Hurd, PhD (2) · Alexandre O Kaup, MD, PhD (1) · Bernard Le Foll, MD, PhD (1) · Beverly S Wical, MD (1) · Brian Martis, MD (1) · Casey Straud, PsyD (1)
PMID 26033282, PMID 27159993, PMID 27573936, PMID 28349233, PMID 29538683, PMID 29619533, PMID 31049885, PMID 32350749, PMID 32652616, PMID 32735782, PMID 33464660, PMID 33730032, PMID 33995015, PMID 34387679, PMID 34391393, PMID 34619044, PMID 35135986, PMID 35537858, PMID 35811050, PMID 36105269, PMID 36123113, PMID 36598543, PMID 37065899, PMID 37482172, PMID 37606606, PMID 37692969, PMID 37811711, PMID 37920963, PMID 38466972, PMID 38770686, PMID 38951902, PMID 39016024, PMID 39252861, PMID 39680411, PMID 39719161, PMID 39849639, PMID 39979051, PMID 40357520, PMID 40410546, PMID 40500407, PMID 40751295, PMID 40803733, PMID 41103807, PMID 41105816, PMID 41469488, PMID 42113179
2014 (3), 2015 (2), P30CA033572 (2), 2009 (1), 2018 (1), 2019 (1), 2025 (1), 5UG3DA048388-03 (1), K01DA049219 (1), KL2TR002646 (1), R01AA029606 (1), R01AT010381 (1), R01AT011341 (1), R01DK122280 (1), R01MH139940 (1)